Neonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort study

ObjectivesTo assess the association between neonatal BCG vaccination and mortality between 28 days and 3 years of age among tuberculosis (TB)-exposed and TB-unexposed children.DesignProspective cohort study.SettingBandim Health Project runs an urban Health and Demographic Surveillance site in Guinea...

Full description

Bibliographic Details
Main Authors: Per Kallestrup, Christine Stabell Benn, Sanne M Thysen, Ane Fisker, Victor Francisco Gomes, Frauke Rudolf, Adam Roth
Format: Article
Language:English
Published: BMJ Publishing Group 2020-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/2/e035595.full
id doaj-e5669e73d0a547dc974ad3bb3aa41717
record_format Article
spelling doaj-e5669e73d0a547dc974ad3bb3aa417172021-07-31T15:32:59ZengBMJ Publishing GroupBMJ Open2044-60552020-02-0110210.1136/bmjopen-2019-035595Neonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort studyPer Kallestrup0Christine Stabell Benn1Sanne M Thysen2Ane Fisker3Victor Francisco Gomes4Frauke Rudolf5Adam Roth6Centre for Global Health, Department of Public Health, Aarhus University, Aarhus, DenmarkOPEN, Department of Clinical Research, University of Southern Denmark, Odense, Denmark 1 OPEN, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark 1 OPEN, University of Southern Denmark, Odense, Denmark Bandim Health Project, Bissau, Guinea-BissauBandim Health Project, Bissau, Guinea-BissauDepartment of Communicable Disease Control and Health Protection, Public Health Agency of Sweden, Solna, Stockholm, SwedenObjectivesTo assess the association between neonatal BCG vaccination and mortality between 28 days and 3 years of age among tuberculosis (TB)-exposed and TB-unexposed children.DesignProspective cohort study.SettingBandim Health Project runs an urban Health and Demographic Surveillance site in Guinea-Bissau with registration of mortality, vaccination status and TB cases.ParticipantsChildren entered the analysis when their vaccination card was inspected after 28 days of age and remained under surveillance to 3 years of age. Children residing in the same house as a TB case were classified as TB-exposed from 3 months prior to case registration to the end of follow-up.MethodsUsing Cox-proportional hazards models with age as underlying time scale, we compared mortality of children with and without neonatal BCG between October 2003 and September 2017.Main outcome measureHR for neonatal BCG compared with no neonatal BCG by TB-exposure status.ResultsAmong the 39 421 children who entered the analyses, 3022 (8%) had observation time as TB-exposed. In total, 84% of children received neonatal BCG. Children with neonatal BCG had lower mortality both in TB-exposed (adjusted HR: 0.57 (0.26 to 1.27)) and in TB-unexposed children (HR: 0.57 (95% CI 0.47 to 0.69)) than children without neonatal BCG. Children exposed to TB had higher mortality than TB-unexposed children if they had not received neonatal BCG.ConclusionNeonatal BCG vaccination was associated with lower mortality among both TB-exposed and TB-unexposed children, consistent with neonatal BCG vaccination having beneficial non-specific effects. Interventions to increase timely BCG vaccination are urgently warranted.https://bmjopen.bmj.com/content/10/2/e035595.full
collection DOAJ
language English
format Article
sources DOAJ
author Per Kallestrup
Christine Stabell Benn
Sanne M Thysen
Ane Fisker
Victor Francisco Gomes
Frauke Rudolf
Adam Roth
spellingShingle Per Kallestrup
Christine Stabell Benn
Sanne M Thysen
Ane Fisker
Victor Francisco Gomes
Frauke Rudolf
Adam Roth
Neonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort study
BMJ Open
author_facet Per Kallestrup
Christine Stabell Benn
Sanne M Thysen
Ane Fisker
Victor Francisco Gomes
Frauke Rudolf
Adam Roth
author_sort Per Kallestrup
title Neonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort study
title_short Neonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort study
title_full Neonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort study
title_fullStr Neonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort study
title_full_unstemmed Neonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort study
title_sort neonatal bcg vaccination and child survival in tb-exposed and tb-unexposed children: a prospective cohort study
publisher BMJ Publishing Group
series BMJ Open
issn 2044-6055
publishDate 2020-02-01
description ObjectivesTo assess the association between neonatal BCG vaccination and mortality between 28 days and 3 years of age among tuberculosis (TB)-exposed and TB-unexposed children.DesignProspective cohort study.SettingBandim Health Project runs an urban Health and Demographic Surveillance site in Guinea-Bissau with registration of mortality, vaccination status and TB cases.ParticipantsChildren entered the analysis when their vaccination card was inspected after 28 days of age and remained under surveillance to 3 years of age. Children residing in the same house as a TB case were classified as TB-exposed from 3 months prior to case registration to the end of follow-up.MethodsUsing Cox-proportional hazards models with age as underlying time scale, we compared mortality of children with and without neonatal BCG between October 2003 and September 2017.Main outcome measureHR for neonatal BCG compared with no neonatal BCG by TB-exposure status.ResultsAmong the 39 421 children who entered the analyses, 3022 (8%) had observation time as TB-exposed. In total, 84% of children received neonatal BCG. Children with neonatal BCG had lower mortality both in TB-exposed (adjusted HR: 0.57 (0.26 to 1.27)) and in TB-unexposed children (HR: 0.57 (95% CI 0.47 to 0.69)) than children without neonatal BCG. Children exposed to TB had higher mortality than TB-unexposed children if they had not received neonatal BCG.ConclusionNeonatal BCG vaccination was associated with lower mortality among both TB-exposed and TB-unexposed children, consistent with neonatal BCG vaccination having beneficial non-specific effects. Interventions to increase timely BCG vaccination are urgently warranted.
url https://bmjopen.bmj.com/content/10/2/e035595.full
work_keys_str_mv AT perkallestrup neonatalbcgvaccinationandchildsurvivalintbexposedandtbunexposedchildrenaprospectivecohortstudy
AT christinestabellbenn neonatalbcgvaccinationandchildsurvivalintbexposedandtbunexposedchildrenaprospectivecohortstudy
AT sannemthysen neonatalbcgvaccinationandchildsurvivalintbexposedandtbunexposedchildrenaprospectivecohortstudy
AT anefisker neonatalbcgvaccinationandchildsurvivalintbexposedandtbunexposedchildrenaprospectivecohortstudy
AT victorfranciscogomes neonatalbcgvaccinationandchildsurvivalintbexposedandtbunexposedchildrenaprospectivecohortstudy
AT fraukerudolf neonatalbcgvaccinationandchildsurvivalintbexposedandtbunexposedchildrenaprospectivecohortstudy
AT adamroth neonatalbcgvaccinationandchildsurvivalintbexposedandtbunexposedchildrenaprospectivecohortstudy
_version_ 1721246778904281088